Polar Capital Holdings Plc

Source: SEC Form 13F · as of Mar 2026

Polar Capital Holdings Plc holds 49 biotech & pharma companies tracked by BioSniper, totaling $3.50B in value as of Mar 2026 (SEC Form 13F).

Companies held

49

Total value held

$3.50B

CompanySharesValue
LLYELI LILLY & Co281,102$258.5M
XENEXenon Pharmaceuticals Inc.4,405,312$256.2M
ELVNEnliven Therapeutics, Inc.5,065,933$198.6M
NUVLNuvalent, Inc.1,831,253$187.6M
BBIOBridgeBio Pharma, Inc.2,519,306$187.1M
TEVATeva Pharmaceutical Industries Limited5,175,058$155.9M
MDGLMADRIGAL PHARMACEUTICALS, INC.289,310$151.4M
REGNREGENERON PHARMACEUTICALS, INC.192,546$148.8M
RYTMRHYTHM PHARMACEUTICALS, INC.1,615,586$140.5M
ARQTArcutis Biotherapeutics, Inc.5,666,940$133.5M
RVMDREVOLUTION MEDICINES, INC.1,133,930$110.3M
CYTKCYTOKINETICS INC1,661,248$109.5M
SRRKScholar Rock Holding Corp1,983,628$97.5M
NAMSNEWAMSTERDAM PHARMA CO N.V.2,831,607$90.6M
DNTHDianthus Therapeutics, Inc. /DE/1,076,009$90.3M
ALNYALNYLAM PHARMACEUTICALS, INC.257,674$85.3M
PCVXVaxcyte, Inc.1,425,788$82.9M
IONSIONIS PHARMACEUTICALS INC829,511$62.3M
INSMINSMED Inc368,107$60.2M
SLNOSOLENO THERAPEUTICS INC1,698,855$56.9M
SVRASavara Inc9,541,786$52.1M
RAPPRapport Therapeutics, Inc.1,642,461$51.4M
ORKAOruka Therapeutics, Inc.1,047,693$51.4M
ZBIOZenas BioPharma, Inc.2,548,444$49.8M
MBXMBX Biosciences, Inc.1,622,186$48.4M
CGONCG Oncology, Inc.704,461$47.7M
APGEApogee Therapeutics, Inc.539,177$45.4M
ROIVRoivant Sciences Ltd.1,578,308$43.7M
NPCENeuropace Inc.3,298,104$43.4M
MLYSMineralys Therapeutics, Inc.1,500,749$40.7M
SYRESpyre Therapeutics, Inc.792,847$40.0M
STOKStoke Therapeutics, Inc.1,132,511$36.9M
MIRMMirum Pharmaceuticals, Inc.283,484$26.2M
TSHATaysha Gene Therapies, Inc.5,654,340$25.3M
DYNDyne Therapeutics, Inc.1,359,169$24.6M
OLMAOlema Pharmaceuticals, Inc.1,602,970$23.9M
PHVSPharvaris N.V.781,016$22.1M
BIOABioAge Labs, Inc.1,132,640$19.8M
IMNMImmunome Inc.849,479$18.6M
KYMRKymera Therapeutics, Inc.215,200$17.9M
GHGuardant Health Inc.173,326$16.0M
CRVSCorvus Pharmaceuticals, Inc.1,070,174$15.7M
MCKMcKesson Corporation17,091$14.8M
ELVElevance Health Inc.42,871$12.6M
MNPRMonopar Therapeutics226,526$12.4M
IVAInventiva S.A.2,132,138$11.8M
ICLRICON plc100,460$11.1M
RLMDRELMADA THERAPEUTICS, INC.1,414,621$9.8M
ORICOric Pharmaceuticals, Inc.539,377$6.8M

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Polar Capital Holdings Plc — Biotech 13F Holdings & Portfolio | BioSniper